Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic Hopes To Disrupt Event-Recorder Space With Corventis Buy

This article was originally published in The Gray Sheet

Executive Summary

Medtronic will exercise its option to acquire Corventis to bring its non-invasive cardiac telemetry technologies to the U.S. and Europe by later this year.

You may also be interested in...



iRhythm Secures $17 Million For Holter Monitor Replacement

The startup will use the Series E funds to support market expansion and evidence collection for its wearable Zio Patch technology and service for detecting heart arrhythmias.

Medtronic Goes Small With Leadless Pacer, Cardiac Monitor

The firm announced the first U.S. implant for its investigational Micra transcatheter, leadless pacing system, and the global launch of its miniature Reveal LINQ implantable cardiac monitor.

Amylyx Relyvrio: Pricing, Compounding, And The Shadow Of Makena

The new ALS product is a fixed-dose combo of two ingredients – sodium phenylbutyrate and taurursodiol – that some patients currently are compounding. Amylyx says it will explore ‘all options’ in addressing that, noting its strong IP for Relyvrio, but also committing to access.

Topics

Related Companies

Related Deals

Latest News
See All
UsernamePublicRestriction

Register

MT033086

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel